𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intermediate-Risk Localized Prostate Cancer in the PSA Era: Radiotherapeutic Alternatives

✍ Scribed by Vinai Gondi; Israel Deutsch; Mahesh Mansukhani; Kathleen M. O’Toole; Jinesh N. Shah; Peter B. Schiff; Aaron E. Katz; Mitchell C. Benson; Erik T. Goluboff; Ronald D. Ennis

Book ID
116947240
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
251 KB
Volume
69
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

International trends in prostate-cancer
International trends in prostate-cancer mortality in the “PSA era”
✍ Steven E. Oliver; Margaret T. May; David Gunnell 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB

Incidence and mortality from prostate cancer were rising in most countries until the late 1980s. Following a number of advances in the management of prostate cancer, including introduction of the prostate-specific antigen (PSA) test, there have been reports of declines in mortality in Canada, the Un

Association between plasma cholesterol a
Association between plasma cholesterol and prostate cancer in the PSA era
✍ Elizabeth A. Platz; Steven K. Clinton; Edward Giovannucci 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB

## Abstract We previously found that statin users had a lower risk of advanced and possibly high‐grade prostate cancer compared with nonusers. We hypothesize that statins' effects on cholesterol synthesis may explain those findings because prostate cancer cells exhibit cholesterol dysregulation. Th